|
[1] TEFFERI A. Pathogenesis of myelofibrosis with myeloid metaplasia[J]. J Clin Oncol,2005,23(33):8520-8530.
|
|
[2] WEBB M,SHIBOLET O,HALPERN Z,et al. Assessment of liver and spleen stiffness in patients with myelofibrosis using FibroScan and Shear wave elastography[J]. Ultrasound Q,2015,31(3):166-169.
|
|
[3] ZHANG L,FU XX,LI X. One case of myelofibrosis with cirrhotic portal hypertension[J]. J Clin Hepatol,2015,31(2):280-281.(in Chinese)张莉，付晓霞，李洵．骨髓纤维化合并肝硬化门静脉高压1例报告[J]．临床肝胆病杂志，2015,31(2):280-281.
|
|
[4] LIU WH,LI H,LIANG YP,et al. A case of primary myelofibrosis with esophageal variceal bleeding[J]. Chin J Gerontol,2014,34(2):532-533.(in Chinese)刘维花，李慧，梁玉萍，等．原发性骨髓纤维化合并食管静脉曲张破裂出血1例[J]．中国老年学杂志，2014,34(2):532-533.
|
|
[5] ARBER DA,ORAZI A,HASSERJIAN R,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood,2016,127(20):2391-2405.
|
|
[6] Chinese Society of Hepatology,Chinese Medical Association.Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol,2019,35(11):2408-2425.(in Chinese)中华医学会肝病学分会．肝硬化诊治指南[J]．临床肝胆病杂志，2019,35(11):2408-2425.
|
|
[7] WAN XH,LU XF. Diagnostics[M]. Beijing:People’s Medical Publishing House,2013:183.(in Chinese)万学红，卢雪峰．诊断学[M]．北京:人民卫生出版社，2013:183.
|
|
[8] CHEN HZ,LIN GW. Practice of internal medicine[M]. Beijing:People’s Medical Publishing House,2009:2419.(in Chinese)陈灏珠，林果为．实用内科学[M]．北京:人民卫生出版社，2009:2419.
|
|
[9] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Prac Hepatol,2018,21(1):21-31.(in Chinese)中华医学会肝病学分会．肝硬化腹水及相关并发症的诊疗指南[J]．实用肝脏病杂志，2018,21(1):21-31.
|
|
[10] HU J,ZHANG FK. The pathomechanism of bone marrow fibrosis[J]. J Clin Hematol,2019,32(4):555-558.(in Chinese)胡靖，张凤奎．骨髓间质纤维化发生的病理机制认识[J]．临床血液学杂志，2019,32(4):555-558.
|
|
[11] KUTER DJ,BAIN B,MUFTI G,et al. Bone marrow fibrosis:Pathophysiology and clinical significance of increased bone marrow stromal fibres[J]. Br J Haematol,2007,139(3):351-362.
|
|
[12] CERVANTES F,DUPRIEZ B,PEREIRA A,et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment[J]. Blood,2009,113(13):2895-2901.
|
|
[13] TEFFERI A,MUDIREDDY M,MANNELLI F,et al. Blast phase myeloproliferative neoplasm:Mayo-AGIMM study of 410 patients from two separate cohorts[J]. Leukemia,2018,32(5):1200-1210.
|
|
[14] ZHONG JP. A case of liver cirrhosis with chronic primary myelofibrosis[J]. J Clin Hepatol,1997,13(3):49-50.(in Chinese)钟建平．肝硬化合并慢性原发性骨髓纤维化一例[J]．临床肝胆病杂志，1997,13(3):49-50.
|
|
[15] DESTERKE C,MARTINAUD C,RUZEHAJI N,et al. Inflammation as a keystone of bone marrow stroma alterations in primary myelofibrosis[J]. Mediators Inflamm,2015,2015:415024.
|
DownLoad: